Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between the ages of 60 and 80
- People who are either very inactive (sedentary) or highly physically active and trained
- People with a body mass index (a measure of body weight relative to height) between 18 and 40
- People who do not smoke
- People whose blood sugar levels are either normal or slightly higher than normal (but not high enough to be diagnosed as diabetes)
- People who are willing and able to follow the study plan and requirements
Who may not be able to join:
- People with health conditions that make moderate exercise unsafe, such as significant heart disease, problems with blood flow in the legs, uncontrolled high blood pressure, or nerve or joint conditions
- People who have recently lost or gained a noticeable amount of weight
- People who have been diagnosed with diabetes
- People who take certain medications known to affect blood sugar levels, such as nicotinic acid (a form of vitamin B3 used as a drug) or steroid medications called glucocorticoids
- People with severe anaemia (low red blood cells), significant problems with fats in the blood, or liver or kidney disease
- People with a recent history of cancer
- People with an underactive thyroid (hypothyroidism)
- People who have recently used hormone replacement therapy
- People with a known allergy to lidocaine or similar local anaesthetic medicines
- People who have had a positive stress test result (a test that checks how the heart responds to physical activity)
- People with current issues related to alcohol or substance use
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Francesca Amati, MD,PhD, University of Lausanne
Phone: +41 21 692 5552
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Insulin sensitivity; Ectopic lipids; Oxidative capacity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.